Anal High Grade Squamous Intraepithelial Lesion clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
Sorry, in progress, not accepting new patients
This is a phase II double blind, placebo-controlled, randomized study of Artesunate suppositories for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
at UCSF
Last updated: